3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients. (September 2015) - Yoshida, T.; Oya, Y.; Tanaka, K.; Junichi, S.; Yoshitsugu, H.; Hida, T.; Yatabe, Y.